Start an analysis for AXP
American Express Company
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $37.9bnEST | 30-Sep-26 | 10-Q filed 23-Oct-26 |
| Remaining authorization | $13.0bnEST | 30-Sep-26 | 10-Q filed 23-Oct-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $1.6bn | 30-Sep-26 | 10-Q filed 23-Oct-26 |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 08-Mar-23 | $37.9bnEST 120.0m sh | $13.0bnEST 41.1m sh left | n/a | On March 8, 2023, the Board of Directors authorized the repurchase of up to 120 million common shares from time to time, subject to market conditions and in accordance with our capital plans. This authorization replaced the prior repurchase authorization.10-Q filed 23-Oct-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Withheld & other | Avg price | ≈ Value | Source |
|---|---|---|---|---|---|
| 30-Sep-26 | 2,063,737 | — | $324.67 | $670m | 10-Q filed 23-Oct-26 |
| 31-Aug-26 | 812,832 | — | $336.09 | $273m | 10-Q filed 23-Oct-26 |
| 31-Jul-26 | 1,901,197 | — | $336.63 | $640m | 10-Q filed 23-Oct-26 |
| 30-Jun-26 | 1,528,850 | 3 | $309.91 | $474m | 10-Q filed 24-Jul-26 |